BioMedbooster is a valorization company. The goal of Biomedbooster is to identify new ideas and technologies, analyse their market potential and assist with further commercial exploitation. For this, BioMedbooster has been granted the unique rights of the University of Maastricht (uM) and the Academic Hospital Maastricht (azM) to facilitate the exploitation of all new inventions in life sciences. This agreement became effective on 15 July 2004. External parties have access to the services of Biomedbooster as well, albeit under distinct conditions.